{"id":842871,"date":"2022-12-14T10:30:10","date_gmt":"2022-12-14T09:30:10","guid":{"rendered":"https:\/\/www.capgemini.com\/?post_type=research-and-insight&#038;p=840028"},"modified":"2025-03-27T10:58:09","modified_gmt":"2025-03-27T10:58:09","slug":"are-decentralized-clinical-trials-the-future","status":"publish","type":"research-and-insight","link":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/","title":{"rendered":"Are decentralized clinical trials the future?"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-reusable header heroReusable  \"><div class=\"header-bgs\"><picture><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=2880&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 1500px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=1440&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 992px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=1024&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=1024&amp;quality=70 2x\" media=\"(min-width: 768px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=768&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=768&amp;quality=70 2x\" media=\"(min-width: 0)\"\/><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg\" class=\"header-img header-img-d\" alt=\"\" style=\"object-fit:cover;object-position:18% 95%\" loading=\"eager\"\/><\/picture><\/div><div class=\"heroPictureCardHeaderShape\"><\/div><div class=\"container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"box\"><div class=\"boxTagWrapper\"><div class=\"tagInfo\"><div><span class=\"box-tag\">Healthcare<\/span><\/div><\/div><div class=\"brandInfo\"><div class=\"brandLogo\"><img decoding=\"async\" loading=\"lazy\" src=\"\/wp-content\/themes\/capgemini2020\/assets\/images\/capgemini-invent.svg\" alt=\"capgemini-invent\"\/><\/div><\/div><\/div><div class=\"box-title\"><h1 data-maxlength=\"34\">Are decentralized clinical trials the future?<\/h1><\/div><div class=\"inner-row-insight download-btn\"><\/div><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para undefined section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><p class=\"intro-para-content-withoutTitle\">In the last few years, there has been a dramatic increase in telemedicine, remote diagnoses, and prescribed treatment. The demand for these services highlighted their profound benefits, not only as a contingency but as a new modus operandi. But why stop at reactionary treatment?<br>\u00a0<br>Another consequence of the pandemic is the realization that we need to rethink the way we develop and deliver new drugs. Perhaps inspired by the rise of blockchain technology, the pharmaceutical industry has embraced the role of decentralization. As a result, many companies are now exploring the impact of Decentralized Clinical Trials (DCTs). New FDA guidance, increasing success of sponsorship, the removal of appointment conflicts, and streamlined data collection are just some of the major benefits.<\/p><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-11 col-lg-10 offset-md-1 offset-lg-1\"><div class=\"article-text article-quote-text\">\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile\"><div class=\"wp-block-media-text__content\">\n<p class=\"has-text-align-center\">Clinical trials are &#8220;pivotal&#8221; phases of drug development. Throughout the years, they\u2019ve enabled patients across the world to access innovative therapies, advanced research, and medical knowledge.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2023\/05\/POV_Decentralized-clinical_Trials.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Download the Report<\/a><\/div>\n<\/div>\n<\/div><figure class=\"wp-block-media-text__media\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Decentralized-Clinical-Trials.png?w=960\" alt=\"\" class=\"wp-image-840029 size-full\"\/><\/figure><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-wrapper-people-slider section section--expert-slider wrapper-people-slider undefined\"><div class=\"container\"><div class=\"content-title\"><h2 data-maxlength=\"34\" class=\"people-heading-title\">Our Experts<\/h2><\/div><\/div><div class=\"slider slider-boxed\"><div class=\"container\"><div class=\"slider-window\"><div class=\"slider-list\">\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/01\/Broderick-Jones-2.jpg\" alt=\"Broderick Jones\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Broderick Jones<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Global Head of Life Science &amp; Med Tech, Capgemini Invent<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">Broderick brings extensive Life Science and Healthcare experience to each client engagement with the goal of driving top-line growth and building capabilities for ongoing commercial success and cost management. His track record of developing high quality business strategies and transformation plans has driven unparalleled customer experience and internal operational excellence globally.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\n\n\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/11\/Damien-Vossion.png\" alt=\"Damien Vossion\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/damien-vossion\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Damien Vossion<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Vice President at Capgemini Invent, Life Sciences &amp; Operating Model<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/damien-vossion\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">I started my career as a consultant in 2000 and gained experience in major transformation projects in Manufacturing, Quality, Supply Chain, and clinical operations, with a strong focus on Industry 4.0 since 2015. I supported General Management in the Life Sciences sector (Pharmaceutical companies, Medical Device companies, and Chemical companies) as well as other large industrial and services companies. I now manage the Life Sciences department at Capgemini Invent in France and co-develop the Life Sciences in Switzerland.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\n\n\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/01\/LECOUTEUX-Barnabe-Perso.jpg\" alt=\"Barnab\u00e9 Lecouteux\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/barnab-lecouteux-a9a31ba\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Barnab\u00e9 Lecouteux<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Senior Director, Data &amp; Analytics for Intelligent Industry, Capgemini Invent<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/barnab-lecouteux-a9a31ba\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">Barnab\u00e9 Lecouteux has 14 years of experience leading strategic and operational projects, with a focus on Data and Artificial Intelligence (AI) topics in the life sciences. He started his career as a consultant for Capgemini on operations transformation in the services, industry and life sciences sectors. Barnab\u00e9 has a total of 8 years of experience in life sciences, first at Ipsen Pharma as Director of Strategic Planning and then at Air Liquide Healthcare, where he held the positions of Head of Chronic Renal Disease BU and Director of Digital Strategy for chronic diseases.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\n\n\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Salma-Benchekroun.png\" alt=\"Salma Benchekroun\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/salmabenchekroun\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Salma Benchekroun<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Pharm. D &amp; ConsultantCapgemini Invent France<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/salmabenchekroun\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div><\/div><\/div><div class=\"slider-nav\"><button class=\"slider-prev inactive\" aria-label=\"Slider-previous\" tabindex=\"-1\"><\/button><ul class=\"slider-paginator\"><\/ul><button class=\"slider-next\" aria-label=\"Slider-next\"><\/button><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>Inspired by the rise of blockchain technology, the pharmaceutical industry has embraced the role of decentralization. As a result, many companies are now exploring the impact of Decentralized Clinical Trials.<\/p>\n","protected":false},"author":290,"featured_media":842872,"template":"","meta":{"cg_dt_proposed_to":[],"_eb_attr":"","cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"c79c1297-02b2-49eb-9079-f9e11f49184f\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":false,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":true,"cg_dt_link_disabled":false,"footnotes":"","related_resource_url":"","related_resource_id":0,"related_resource_size":"","related_resource_type":"","cg_author":0,"_yoast_wpseo_primary_theme":382,"primary_term":"Healthcare","featured_focal_points":""},"tags":[],"research-and-insight-type":[72],"theme":[382],"brand":[601],"service":[],"industry":[],"partners":[],"content-group":[],"class_list":["post-842871","research-and-insight","type-research-and-insight","status-publish","has-post-thumbnail","hentry","research-and-insight-type-point-of-view","theme-health","brand-capgemini-invent"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Are decentralized clinical trials the future? - Capgemini Belgium<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Are decentralized clinical trials the future?\" \/>\n<meta property=\"og:description\" content=\"Inspired by the rise of blockchain technology, the pharmaceutical industry has embraced the role of decentralization. As a result, many companies are now exploring the impact of Decentralized Clinical Trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini Belgium\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-27T10:58:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2025\/10\/New-Web-preview-global.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\",\"url\":\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\",\"name\":\"Are decentralized clinical trials the future? - Capgemini Belgium\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/be-en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg\",\"datePublished\":\"2022-12-14T09:30:10+00:00\",\"dateModified\":\"2025-03-27T10:58:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg\",\"width\":2880,\"height\":1800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Research &amp; insights\",\"item\":\"https:\/\/www.capgemini.com\/be-en\/research-and-insight\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Are decentralized clinical trials the future?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/be-en\/#website\",\"url\":\"https:\/\/www.capgemini.com\/be-en\/\",\"name\":\"Capgemini Belgium\",\"description\":\"Capgemini\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/be-en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Are decentralized clinical trials the future? - Capgemini Belgium","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/","og_locale":"en_US","og_type":"article","og_title":"Are decentralized clinical trials the future?","og_description":"Inspired by the rise of blockchain technology, the pharmaceutical industry has embraced the role of decentralization. As a result, many companies are now exploring the impact of Decentralized Clinical Trials.","og_url":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/","og_site_name":"Capgemini Belgium","article_modified_time":"2025-03-27T10:58:09+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2025\/10\/New-Web-preview-global.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/","url":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/","name":"Are decentralized clinical trials the future? - Capgemini Belgium","isPartOf":{"@id":"https:\/\/www.capgemini.com\/be-en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg","datePublished":"2022-12-14T09:30:10+00:00","dateModified":"2025-03-27T10:58:09+00:00","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#primaryimage","url":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg","contentUrl":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg","width":2880,"height":1800},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Research &amp; insights","item":"https:\/\/www.capgemini.com\/be-en\/research-and-insight\/"},{"@type":"ListItem","position":2,"name":"Are decentralized clinical trials the future?"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/be-en\/#website","url":"https:\/\/www.capgemini.com\/be-en\/","name":"Capgemini Belgium","description":"Capgemini","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/be-en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"theme_term_info":[{"id":382,"name":"Health"}],"industry_term_info":[],"services_term_info":[],"partners_term_info":[],"brand_term_info":[{"id":601,"name":"Capgemini Invent","slug":"capgemini-invent"}],"brand_term":[{"id":601,"slug":"capgemini-invent"}],"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Are decentralized clinical trials the future?","url":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini Belgium","logo":""},"keywords":[],"dateCreated":"2022-12-14T09:30:10Z","datePublished":"2022-12-14T09:30:10Z","dateModified":"2025-03-27T10:58:09Z"},"rendered":"<meta name=\"parsely-title\" content=\"Are decentralized clinical trials the future?\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/be-en\/insights\/research-library\/are-decentralized-clinical-trials-the-future\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2022-12-14T09:30:10Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg","featured_image_alt":"","distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini Belgium","distributor_original_site_url":"https:\/\/www.capgemini.com\/be-en","push-errors":false,"tag_names":[],"featured_image_url":"https:\/\/www.capgemini.com\/be-en\/wp-content\/uploads\/sites\/14\/2022\/12\/Decentralized-Clinical-Trials-Web-banner.jpg","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/research-and-insight\/842871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/research-and-insight"}],"about":[{"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/types\/research-and-insight"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/users\/290"}],"version-history":[{"count":2,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/research-and-insight\/842871\/revisions"}],"predecessor-version":[{"id":872852,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/research-and-insight\/842871\/revisions\/872852"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/media\/842872"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/media?parent=842871"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/tags?post=842871"},{"taxonomy":"research-and-insight-type","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/research-and-insight-type?post=842871"},{"taxonomy":"theme","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/theme?post=842871"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/brand?post=842871"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/service?post=842871"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/industry?post=842871"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/partners?post=842871"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/be-en\/wp-json\/wp\/v2\/content-group?post=842871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}